Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 17, 2020

SELL
$26.36 - $49.86 $590,200 - $1.12 Million
-22,390 Closed
0 $0
Q1 2020

May 12, 2020

BUY
$17.27 - $40.17 $154,670 - $359,762
8,956 Added 66.67%
22,390 $669,000
Q4 2019

Feb 14, 2020

BUY
$32.1 - $40.4 $431,231 - $542,733
13,434 New
13,434 $453,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $12.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Schf (Gpe), LLC Portfolio

Follow Schf (Gpe), LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schf (Gpe), LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schf (Gpe), LLC with notifications on news.